Safety Review Ordered for Pradaxa

Pradaxa/ Blood Clots/ Blood Thinners

The U.S. Food and Drug Administration announced this week that it will conduct a complete safety review of the drug, Pradaxa (dabigatran), following reports that it may cause excessive bleeding. Pradaxa is an oral direct thrombin inhibitor that is used to prevent stroke in patients suffering from nonvalvular atrial fibrillation. The FDA’s safety review announcement [...]